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Retinoids in patterning: Chimeras win by a knockout
Malcolm Maden
Recent studies on the regenerating newt limb, using
cells transfected with chimeric retinoic acid receptors
that can be activated by thyroid hormone, have
provided unique insights into the function of specific
retinoic acid receptor isoforms.
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When you look in the mirror and see those wrinkles, don’t
despair. Rub some retinoic acid cream on them and they
will disappear! This, together with other pharmaceutically
important controls of epithelial differentiation [1], is
among the many pleiotropic effects that retinoids —
vitamin A and its derivatives — have on our bodies. Other
roles are in vision, reproduction, haematopoiesis, the
immune system and the prevention of various forms of
cancer [2]. Our embryos, too, need a precisely regulated
supply of retinoids [3,4]. Hypovitaminosis A has
extremely severe effects on the cardiovascular system,
nervous system, eyes, face, teeth, ears, limbs, skin, lungs
and urinogenital system of avian and mammalian embryos.
Conversely, an excess of retinoids, and in particular of
retinoic acid, is teratogenic to the embryos of vertebrates,
resulting in a similar spectrum of abnormalities [5,6].
Sadly, this is also true of human embryos [6].
Retinoic acid is thus a molecule required for the proper
development of the embryo, and some of the most inter-
esting effects on embryos have been seen in developing
and regenerating limbs. Excess retinoic acid administered
to the developing chick limb bud induces the growth of an
extra limb, and the two limbs grow side-by-side in mirror
symmetry [3,4]. In the regenerating amphibian limb,
retinoic acid induces an extra limb to grow on the end of
the original one, making it twice as long [3,4]. Most
remarkably, retinoic acid can transform regenerating frog
tadpole tails into limbs [7].
How can one molecule have such incredibly diverse effects
on developing cells and tissues? Even within a single
system, the regenerating amphibian limb, during the
process of inducing extra limb outgrowth retinoic acid has
at least 12 distinguishable effects on the cells of the
blastema, such as excessive dedifferentiation, cell clump-
ing, epidermal metaplasia, keratin changes, and so on [8].
At least part of the explanation for this range of effects has
come from studying the mechanism of action of retinoids
in the cell, and the discovery of a family of nuclear retinoic
acid receptors (RARs) [9,10]. These nuclear receptors act
as ligand-activated transcription factors, and have provided
a molecular basis for the pleiotropic effects of retinoids in
the following way. There are three RAR genes — RARa,
RARb and RARg — and several isoforms of each gene, the
major ones being a1, a2, b1, b2, b3, b4, g1 and g2. Within
the regenerating newt limb, five RAR isoforms are
expressed: a1, a2, d1a, d1b and d2 (the newt d is equivalent
to the mammalian g). A second family of receptors was
subsequently discovered, the so-called retinoid X receptors
(RXRs), with three family members (a, b and g) and a
similar range of isoforms. The RARs and RXRs can hetero-
dimerize before binding to retinoic acid response elements
in the DNA, and with all these isoforms available the
number of possible combinations is enormous.
Do individual isoforms have a function?
Two pieces of evidence have suggested that individual
RAR and RXR isoforms may have unique functions in
developing embryos and adult tissues. Firstly, amino-acid
sequence comparisons have revealed that the interspecies
conservation of a given RAR family member is greater
than the similarity between the three RAR genes within a
given species, and this is particularly so in the amino-ter-
minal ‘A regions’ of the various isoforms. Secondly, each
RAR isoform has a distinct spatio-temporal expression
pattern in the developing embryo.
On the basis of gene expression data from many studies of
the mouse embryo, one would suggest the following func-
tions for each RAR. RARa is generally considered to be
ubiquitous, but in early embryos it would have a function
in neural tube development from the anterior hindbrain
backwards, in migrating neural crest and some of its deriv-
atives, in the dental epithelium and in several individual
organs (liver, thyroid and thymus). RARb would function
in endoderm development, in presomitic mesoderm, in
motorneuron development, in the heart, in the frontonasal
mass, in the eyes (particularly the retina and optic nerve),
in interdigital cell death and in various organ epithelia
(tracheal, bronchial, genital and olfactory). RARg would
function in neurulation, in the structures that make up the
face, in dental mesenchyme, in cartilage differentiation
and in the skin.
It must be remembered, however, that we know nothing
about the protein distribution of these receptors in the
mammalian embryo: the data described above are all
patterns of transcription, detected by in situ hybridization
and with no resolution at the cellular level. In the only
immunohistological study performed to date, using anti-
bodies to the d1 isoform in the newt limb [11], it was
found that 50 % of nuclei in all differentiated tissues were
immunoreactive, and in the regenerating blastema the
percentage of immunoreactive cells increased.
Two different approaches have been used to test the func-
tion of the RARs and their isoforms. The most obvious
one is to use homologous recombination techniques in
mice to ‘knock out’ the RAR genes one by one and look
for abnormalities in the embryos. An alternative is to put
each successively under the control of an alternative
ligand and then see which of the pleiotropic effects the
alternative ligand induces. It should be emphasized that
these are not equivalent approaches: the former is con-
cerned with the function of endogenous isoforms, whereas
the latter is concerned with how the isoforms function in
the presence of excess retinoic acid.
Knockouts
Surprisingly, when individual RAR isoforms — RARa1,
RARb2 and RARg2 — are genetically knocked out, the
phenotype of the mouse embryo is unaltered [12]. More
surprisingly still, normal embryos are produced when all of
the RARb isoforms are knocked out simultaneously. A
knockout of all the RARa isoforms does give a phenotype
— postnatal lethality, testis degeneration and webbed
digits — as does a knockout of all the RARg isoforms,
which gives postnatal lethality, growth deficiency, transfor-
mations of certain vertebrae, malformations of tracheal car-
tilages, Harderian gland agenesis and squamous metaplasia
of the seminal vesicles and prostate. None of these pheno-
types is what might have been expected from the gene
expression patterns. It is not until isoforms for two of the
three RAR genes are knocked out together that embryonic
malformations appear which resemble those associated
with vitamin A deficiency. Thus, abnormalities of the
respiratory tract, heart outflow tract, aortic arch, genital
tract and eye appear in such double mutants as b2/g, a/g,
a/b2, and so on. In addition, other abnormalities appear
which are not associated with the vitamin-deficiency synd-
rome, such as skeletal and glandular abnormalities.
These results are clearly contrary to the prediction that
each isoform has a specific function. Furthermore, the
glaring omission from all these embryonic abnormalities is
the best-known and pharmaceutically important effect on
skin (and wrinkles): all the mutant mice have failed to
reveal any dramatic changes in the morphology of the
epidermis. The standard explanation for these contrasting
results is functional redundancy at the molecular level —
different receptors can substitute for each other — which
implies that receptor isoforms do not have individual func-
tions. But there is also good evidence which seems to
support the conclusion that individual isoforms do indeed
have distinct functions.
Chimeric receptors 
In contrast to the results with knockouts, the approach
that Brockes and his colleagues have taken in studies of
the regenerating newt limb has produced results which do
demonstrate functions for individual isoforms. The
method used is to swap the ligand-binding domain of a
particular RAR isoform with that taken from a thyroid
hormone receptor, thereby making a chimeric receptor
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Figure 1
The assay system of intercalary regeneration used by Pecorino,
Entwistle and Brockes [17] to determine which receptor isoform is
responsible for proximalization of distal blastemal cells; (a) is an
explanation of cellular behaviour during normal intercalary regeneration,
(b) is what happens to the cellular contributions when the distal
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that is responsive to thyroid hormone rather than retinoic
acid, but which still activates the appropriate retinoic acid-
responsive genes. A range of such chimeric receptors are
then transfected one by one back into newt limb blastemal
cells, either in vitro or in vivo, using biolistics (biolistics has
been reviewed previously in Current Biology [13]).
In this way Schilthius, Gann and Brockes [14] showed that
when the a1 chimera was transfected into blastemal cells
they became growth-inhibited (one of the 12 characterized
effects of retinoic acid on the blastema) in response to
thyroid hormone. Only the a1 chimera behaved in this
way; there was no response with other chimeras. Further-
more, the region required for this specificity proved to be
the A region of the receptor [15]. Thus, the conclusion
from this study was that the function of RARa1 is to
induce growth inhibition in response to retinoic acid. A
similar experiment by Pecorino, Lo and Brockes [16],
examining the induction of an antibody marker in the
wound epidermis in response to retinoic acid, produced
the clear result that this cellular behaviour was induced by
the d1 isoform.
The latest chapter in this story, reported in the May issue
of Current Biology [17], is the most exciting result so far
because it concerns the effect that retinoic acid has on the
patterning of blastemal cells. When retinoic acid induces a
complete limb to regrow from an amputation plane
through the wrist or forearm, thus generating two limbs in
tandem, it respecifies distal (wrist or lower arm) blastemal
cells to become more proximal (upper arm or shoulder). It
is known that this involves a change in the cell-surface
properties of blastema cells because the behaviour of
retinoic acid-treated distal cells changes to become more
like proximal cells in an assay known as intercalary regen-
eration (see Fig. 1). Intercalary regeneration is the process
whereby the gap is ‘filled in’ when a distal blastema is
grafted to a proximal stump (Fig. 1a). Normally the cells
that do this filling-in come entirely from the proximal
stump, and the cells of the distal grafted blastema make
no contribution. But when the distal grafted blastema has
been treated with retinoic acid, the cells become proxi-
malized and make a significant contribution to the process
of filling-in (Fig. 1b). 
Pecorino, Entwistle and Brockes [17] asked which RAR
isoform is responsible for this pattern respecification by
retinoic acid. They made chimeric receptors for each of
the five isoforms, transfected them individually into distal
blastemas and treated the blastemas not with retinoic acid
but with thyroid hormone. The distribution of the transf-
ected cells from the distal blastema in the intercalary
regenerate was analysed using fluorescence and a confocal
microscope. Only when the cells were transfected with the
chimeric d2 receptor did the distribution of cells in the
intercalary regenerate change from being distal (normal
and not responding to thyroid hormone with pattern
changes) to proximal (responding to thyroid hormone with
pattern changes). The conclusion is therefore that the d2
isoform is responsible for the proximalization of blastemal
cells by retinoic acid.
Thus, the work of Brockes and colleagues on newt limb
regeneration has so far produced a unique function for
three of the five RAR isoforms known to be present. The
a1 isoform mediates the growth inhibition of blastemal
cells; the d1 isoform mediates the antigenic change of
wound epidermis cells; and the d2 isoform mediates posi-
tional change in the proximo-distal axis. The clear conclu-
sion from this work is that RAR isoforms have unique
functions and no redundancy. These researchers are now
in a strong position to identify the target genes that these
isoforms activate, and so to reach the ultimate goal —
identification of the molecular mechanisms of positional
change.
In the work on the mammalian embryo, such isoform
specificity has been concluded from analyses of their tissue
distribution and from amino-acid sequence comparisons,
but experimental tests using gene knockouts have only
demonstrated redundancy, not specific functions. A solu-
tion to the apparent contradiction between these results
and those of Brockes and colleagues can be proposed if we
assume that the knockout results have revealed cellular
redundancy, but not molecular redundancy. Thus, if an
organ or embryonic field of cells normally develops as a
result of an interaction between at least two tissues, and if
the cells of each of these tissues express a unique
RAR/RXR isoform profile, with each isoform performing a
unique function, then knocking out a single isoform might
prevent the function of that group of cells in which the
isoform is expressed, but the organ might be able to
develop successfully without the contribution of these
cells which simply cease to function . This cellular comple-
mentation would be an example of a classical embryologi-
cal phenomenon known as ‘double assurance’, which
occurs in skeletal muscle lineages and explains the lack of
phenotype in knockouts of individual myogenic genes
[18]. It seems highly relevant to the results described here
for the retinoid receptors.
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